2017 Form 10-K Financial Statement
#000143774918005827 Filed on March 29, 2018
Income Statement
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
Revenue | $6.862M | $1.410M | $6.102M |
YoY Change | 12.45% | -5.37% | -10.58% |
Cost Of Revenue | $2.824M | $510.0K | $2.183M |
YoY Change | 29.36% | -7.27% | -13.72% |
Gross Profit | $4.038M | $900.0K | $3.919M |
YoY Change | 3.04% | -4.26% | -8.73% |
Gross Profit Margin | 58.85% | 63.83% | 64.22% |
Selling, General & Admin | $2.625M | $610.0K | $2.827M |
YoY Change | -7.15% | -17.57% | -9.42% |
% of Gross Profit | 65.01% | 67.78% | 72.14% |
Research & Development | $2.162M | $590.0K | $2.499M |
YoY Change | -13.49% | -11.94% | 7.95% |
% of Gross Profit | 53.54% | 65.56% | 63.77% |
Depreciation & Amortization | $206.0K | $70.00K | $291.0K |
YoY Change | -29.21% | -12.5% | -2.68% |
% of Gross Profit | 5.1% | 7.78% | 7.43% |
Operating Expenses | $4.787M | $1.200M | $5.326M |
YoY Change | -10.12% | -14.89% | -2.02% |
Operating Profit | -$749.0K | -$300.0K | -$1.407M |
YoY Change | -46.77% | -36.17% | 23.2% |
Interest Expense | -$209.0K | -$40.00K | -$145.0K |
YoY Change | 44.14% | 33.33% | 35.51% |
% of Operating Profit | |||
Other Income/Expense, Net | $928.0K | ||
YoY Change | |||
Pretax Income | -$30.00K | -$340.0K | -$1.552M |
YoY Change | -98.07% | -32.0% | 24.26% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$30.00K | -$340.0K | -$1.552M |
YoY Change | -98.07% | -32.0% | 24.26% |
Net Earnings / Revenue | -0.44% | -24.11% | -25.43% |
Basic Earnings Per Share | -$0.01 | -$0.13 | |
Diluted Earnings Per Share | -$0.01 | -$26.67K | -$0.13 |
COMMON SHARES | |||
Basic Shares Outstanding | 12.84M | 12.74M | |
Diluted Shares Outstanding | 12.84M | 12.74M |
Balance Sheet
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $200.0K | $100.0K | $100.0K |
YoY Change | 100.0% | 0.0% | 0.0% |
Cash & Equivalents | $200.0K | $64.00K | $100.0K |
Short-Term Investments | |||
Other Short-Term Assets | $100.0K | $100.0K | $100.0K |
YoY Change | 0.0% | 0.0% | 0.0% |
Inventory | $0.00 | $45.00K | $0.00 |
Prepaid Expenses | $75.00K | ||
Receivables | $1.000M | $745.0K | $700.0K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $1.300M | $929.0K | $900.0K |
YoY Change | 44.44% | 16.71% | 12.5% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $100.0K | $308.0K | $300.0K |
YoY Change | -66.67% | -36.63% | -40.0% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $40.00K | $0.00 |
YoY Change | -6.98% | ||
Total Long-Term Assets | $200.0K | $348.0K | $400.0K |
YoY Change | -50.0% | -34.22% | -20.0% |
TOTAL ASSETS | |||
Total Short-Term Assets | $1.300M | $929.0K | $900.0K |
Total Long-Term Assets | $200.0K | $348.0K | $400.0K |
Total Assets | $1.500M | $1.277M | $1.300M |
YoY Change | 15.38% | -3.62% | 0.0% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $200.0K | $205.0K | $200.0K |
YoY Change | 0.0% | -6.82% | 0.0% |
Accrued Expenses | $1.000M | $691.0K | $700.0K |
YoY Change | 42.86% | 11.45% | 16.67% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $0.00 | $100.0K | $100.0K |
YoY Change | -100.0% | -50.0% | -50.0% |
Total Short-Term Liabilities | $2.100M | $1.733M | $1.700M |
YoY Change | 23.53% | 9.48% | 6.25% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $2.900M | $2.900M | $2.900M |
YoY Change | 0.0% | 70.59% | 70.59% |
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $2.900M | $2.900M | $2.900M |
YoY Change | 0.0% | 70.59% | 70.59% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.100M | $1.733M | $1.700M |
Total Long-Term Liabilities | $2.900M | $2.900M | $2.900M |
Total Liabilities | $5.000M | $4.700M | $4.700M |
YoY Change | 6.38% | 42.42% | 42.42% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$61.50M | ||
YoY Change | 2.59% | ||
Common Stock | $128.0K | ||
YoY Change | 1.59% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $362.0K | ||
YoY Change | 0.0% | ||
Treasury Stock Shares | $10.00K | ||
Shareholders Equity | -$3.500M | -$3.402M | -$3.400M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $1.500M | $1.277M | $1.300M |
YoY Change | 15.38% | -3.62% | 0.0% |
Cashflow Statement
Concept | 2017 | 2016 Q4 | 2016 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$30.00K | -$340.0K | -$1.552M |
YoY Change | -98.07% | -32.0% | 24.26% |
Depreciation, Depletion And Amortization | $206.0K | $70.00K | $291.0K |
YoY Change | -29.21% | -12.5% | -2.68% |
Cash From Operating Activities | $272.0K | -$630.0K | -$1.244M |
YoY Change | -121.86% | -31.52% | 94.38% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $20.00K | -$10.00K | $47.00K |
YoY Change | -57.45% | 0.0% | -61.16% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $60.00K | ||
YoY Change | |||
Cash From Investing Activities | $36.00K | -$10.00K | -$47.00K |
YoY Change | -176.6% | 0.0% | -60.83% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -148.0K | 490.0K | 1.253M |
YoY Change | -111.81% | -1080.0% | -935.33% |
NET CHANGE | |||
Cash From Operating Activities | 272.0K | -630.0K | -1.244M |
Cash From Investing Activities | 36.00K | -10.00K | -47.00K |
Cash From Financing Activities | -148.0K | 490.0K | 1.253M |
Net Change In Cash | 160.0K | -150.0K | -38.00K |
YoY Change | -521.05% | -84.69% | -95.82% |
FREE CASH FLOW | |||
Cash From Operating Activities | $272.0K | -$630.0K | -$1.244M |
Capital Expenditures | $20.00K | -$10.00K | $47.00K |
Free Cash Flow | $252.0K | -$620.0K | -$1.291M |
YoY Change | -119.52% | -31.87% | 69.65% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2017Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1123000 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P2Y273D | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P3Y3D | |
CY2017 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1870000 | |
CY2016 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1355000 | |
CY2017 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
56000 | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | |
CY2017 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y | |
CY2017Q4 | intz |
Capital Leases Future Minimum Payments Due In Four Years And Thereafter
CapitalLeasesFutureMinimumPaymentsDueInFourYearsAndThereafter
|
||
CY2017Q4 | intz |
Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
|
0.3 | |
CY2017 | intz |
Defined Contribution Plan Minimum Age Required For Contribution Of Additional Amount Of Salary Per Year
DefinedContributionPlanMinimumAgeRequiredForContributionOfAdditionalAmountOfSalaryPerYear
|
P50Y | |
CY2017 | intz |
Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
|
11476000 | |
CY2016 | intz |
Effective Income Tax Rate Reconciliation Remeasurement Of Deferred Taxes
EffectiveIncomeTaxRateReconciliationRemeasurementOfDeferredTaxes
|
||
CY2017 | intz |
Number Of Major United States Financial Institutions
NumberOfMajorUnitedStatesFinancialInstitutions
|
2 | |
CY2017 | intz |
Number Of Operating Leases
NumberOfOperatingLeases
|
2 | |
CY2016Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
139000 | |
CY2017Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
17000 | |
CY2017Q4 | intz |
Number Of Stockbased Compensation Plans
NumberOfStockbasedCompensationPlans
|
2 | |
CY2017Q4 | intz |
Operating Leases Future Minimum Payments Due In Three Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsAndThereafter
|
104000 | |
CY2017 | intz |
Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
|
33000 | |
CY2016 | intz |
Penalties And Waived Penalties On Dividends
PenaltiesAndWaivedPenaltiesOnDividends
|
20000 | |
CY2017 | intz |
Period Of Payment Terms Offered To Customers Distributions And Resellers Domestically
PeriodOfPaymentTermsOfferedToCustomersDistributionsAndResellersDomestically
|
P30D | |
CY2017 | intz |
Period Of Payment Terms Offered To Customers Distributors And Resllers Internationally
PeriodOfPaymentTermsOfferedToCustomersDistributorsAndResllersInternationally
|
P45D | |
CY2017 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period1
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod1
|
P1Y | |
CY2017 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period2
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod2
|
P3Y | |
CY2017 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Award Exercisable Period3
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardExercisablePeriod3
|
P5Y | |
CY2017 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
|
24000 | |
CY2016 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Equal To Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceEqualToMarketValue
|
69000 | |
CY2017 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
|
||
CY2016 | intz |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Gross At Price Greater Than Market Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossAtPriceGreaterThanMarketValue
|
||
CY2017 | intz |
Sharebased Compensation Arrangements By Sharebased Payment Award Options Expiration Term For Options Granted To Holders Of More Than Specified Percentage Of Voting Stock
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExpirationTermForOptionsGrantedToHoldersOfMoreThanSpecifiedPercentageOfVotingStock
|
P5Y | |
CY2017 | intz |
Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
|
0.42 | |
CY2016 | intz |
Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Equal To Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceEqualToMarketValue
|
0.36 | |
CY2017 | intz |
Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
|
||
CY2016 | intz |
Sharebased Compensation Arrangements By Sharebased Payment Award Options Grants In Period Weighted Average Exercise Price Greater Than Market Value
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceGreaterThanMarketValue
|
||
CY2017Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
194000 | |
CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
205000 | |
CY2017Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
962000 | |
CY2016Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
745000 | |
CY2017Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
988000 | |
CY2016Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
691000 | |
CY2017Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
139000 | |
CY2016Q4 | us-gaap |
Accrued Rent Current
AccruedRentCurrent
|
13000 | |
CY2017Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
131000 | |
CY2016Q4 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
134000 | |
CY2017Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
284000 | |
CY2016Q4 | us-gaap |
Accrued Vacation Current
AccruedVacationCurrent
|
279000 | |
CY2017Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1695000 | |
CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1491000 | |
CY2017Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-107000 | |
CY2016Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-107000 | |
CY2017Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
56518000 | |
CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
56595000 | |
CY2017Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | |
CY2016Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | |
CY2017 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2941861 | |
CY2016 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3509241 | |
CY2017Q4 | us-gaap |
Assets
Assets
|
1452000 | |
CY2016Q4 | us-gaap |
Assets
Assets
|
1277000 | |
CY2017Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1290000 | |
CY2016Q4 | us-gaap |
Assets Current
AssetsCurrent
|
929000 | |
CY2017 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
||
CY2016 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
66000 | |
CY2017Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
62000 | |
CY2017Q4 | us-gaap |
Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
|
44000 | |
CY2016Q4 | us-gaap |
Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
|
61000 | |
CY2017Q4 | us-gaap |
Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
|
61000 | |
CY2017Q4 | us-gaap |
Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
|
45000 | |
CY2017Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
|
||
CY2017Q4 | us-gaap |
Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
|
17000 | |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
224000 | |
CY2016Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
64000 | |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
102000 | |
CY2017 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
160000 | |
CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-38000 | |
CY2017Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2016Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2017Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
3319943 | |
CY2017Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2017Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
80000000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12808000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
12758000 | |
CY2017Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
12798000 | |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
12748000 | |
CY2017Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
128000 | |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
128000 | |
CY2017 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Risk Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">Financial instruments, which potentially subject us <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">to concentrations of credit risk, are primarily cash and cash equivalents, investments and accounts receivable. Cash and cash equivalent deposits are at risk to the extent that they exceed Federal Deposit Insurance Corporation insured amounts. To minimize risk, we place our investments in U.S. government obligations, corporate securities and money market funds. Substantially all of our cash, cash equivalents and investments are maintained with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> major U.S. financial institutions. We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe that we are subject to any unusual financial risk with our banking arrangements. We have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any significant losses on our cash and cash equivalents.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We sell our products to customers in diversified industries worldwide and periodically have rec<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">eivables from customers, primarily in North America, Europe and Asia. Fluctuations in currency exchange rates and adverse economic developments in foreign countries could adversely affect the Company’s operating results. We perform ongoing credit evaluations of our customers’ financial condition and generally require <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> collateral. We maintain reserves for potential credit losses, and such losses, in the aggregate, have historically been minimal.</div></div></div></div></div></div></div></div></div></div></div></div> | |
CY2017 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2824000 | |
CY2016 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2183000 | |
CY2017Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
406000 | |
CY2016Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
395000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
21654000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
33132000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
||
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
21175000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
32644000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
374000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
|
374000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
94000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
124000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
25000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
|
38000 | |
CY2017Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
21654000 | |
CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
33132000 | |
CY2017Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
14000 | |
CY2016Q4 | us-gaap |
Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
|
48000 | |
CY2017 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
30000 | |
CY2016 | us-gaap |
Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
|
32000 | |
CY2017 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
|
0.04 | |
CY2017 | us-gaap |
Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
|
0.0025 | |
CY2017 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
206000 | |
CY2016 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
291000 | |
CY2017Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
447000 | |
CY2016Q4 | us-gaap |
Dividends Payable Current
DividendsPayableCurrent
|
303000 | |
CY2017Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
139000 | |
CY2016Q4 | us-gaap |
Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
|
139000 | |
CY2017 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.01 | |
CY2016 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.13 | |
CY2017 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.01 | |
CY2016 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.13 | |
CY2017 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y40D | |
CY2017Q4 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
12000 | |
CY2017Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
43000 | |
CY2016Q4 | us-gaap |
Furniture And Fixtures Gross
FurnitureAndFixturesGross
|
43000 | |
CY2017 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
56000 | |
CY2016 | us-gaap |
Gain On Sale Of Investments
GainOnSaleOfInvestments
|
||
CY2017 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1094000 | |
CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1190000 | |
CY2017 | us-gaap |
Gross Profit
GrossProfit
|
4038000 | |
CY2016 | us-gaap |
Gross Profit
GrossProfit
|
3919000 | |
CY2017 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2016 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
0 | |
CY2017 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-30000 | |
CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1552000 | |
CY2017Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
CY2016Q4 | us-gaap |
Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
|
0 | |
CY2017 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
||
CY2017 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-11478000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
890000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
||
CY2016 | us-gaap |
Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
|
-345000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-10000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-528000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
11000 | |
CY2016 | us-gaap |
Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
|
28000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
||
CY2016 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-43000 | |
CY2017 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
||
CY2016 | us-gaap |
Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
|
38000 | |
CY2017 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
1000 | |
CY2016 | us-gaap |
Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
|
-40000 | |
CY2017 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
||
CY2016 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
||
CY2017 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
291000 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
60000 | |
CY2017 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
217000 | |
CY2016 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
165000 | |
CY2017 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
11000 | |
CY2016 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
9000 | |
CY2017 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-30000 | |
CY2016 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
||
CY2017 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
14000 | |
CY2016 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
6000 | |
CY2017 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-209000 | |
CY2016 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-145000 | |
CY2017 | us-gaap |
Interest Paid Net
InterestPaidNet
|
6000 | |
CY2016 | us-gaap |
Interest Paid Net
InterestPaidNet
|
14000 | |
CY2017Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
348000 | |
CY2016Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
184000 | |
CY2017Q4 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
1000 | |
CY2017Q4 | us-gaap |
Inventory Net
InventoryNet
|
15000 | |
CY2016Q4 | us-gaap |
Inventory Net
InventoryNet
|
45000 | |
CY2017 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
20000 | |
CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
47000 | |
CY2017 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
139000 | |
CY2016 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
139000 | |
CY2017Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2017Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | |
CY2017Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
89000 | |
CY2016Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
75000 | |
CY2017 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
||
CY2016 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
364000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
272000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1244000 | |
CY2017 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-30000 | |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1733000 | |
CY2017Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
1721000 | |
CY2016Q4 | us-gaap |
Machinery And Equipment Gross
MachineryAndEquipmentGross
|
1708000 | |
CY2017 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Description of Business</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We develop, market, and support a family of entity identification, data mining, regulated in<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">formation compliance and data privacy protection. Our product families include: TraceCop for identity identification, Savant for data mining and advanced persistent threat detection and Compliance Commander for regulated information and data privacy protection. Intrusion’s products help protect critical information assets by quickly detecting, protecting, analyzing and reporting attacks or misuse of classified, private and regulated information for government and enterprise networks.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">We market and distr<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">ibute our products through a direct sales force to end-users, distributors and numerous system integrators, managed service providers and value-added resellers. Our end-user customers include banks, credit unions, other financial institutions, U.S. federal government entities, foreign government entities, hospitals and other healthcare providers. Essentially, our end-users can be defined as end-users requiring network security solutions for protecting their mission critical data.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">References to the “<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">Company”, “we”, “us”, “our”, “Intrusion” or “Intrusion Inc.” refer to Intrusion Inc. and its subsidiaries. Compliance Commander™ and TraceCop™ are registered trademarks of Intrusion Inc.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>we had cash and cash equivalents of approximatel<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">y <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$224,000,</div> up from approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$64,000</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>We generated a net loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017 </div>compared to net loss of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,552,000</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>The net loss in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> included other income of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">928,000,</div> of which</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$872,000</div> came from the sale of certain unused IP addresses and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$56,000</div> from the sale of an investment. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2018, </div>in addition to cash and cash equivalents, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$835,000</div> of funding is available from a promissory note to borrow up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3.7</div> million from G. Ward Paxton, the Company’s Chief Executive Officer. We are obligated to make payments of accrued dividends on all our outstanding shares of preferred stock that will reduce our available cash resources. Based on projections of growth in revenue and net income in the coming quarters, and the borrowings available previously mentioned, we believe that we will have sufficient cash resources to finance our operations and expected capital expenditures through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2019. </div>We expect to fund our operations through anticipated Company profits, borrowings from the Company’s CEO, and possibly additional investments of private equity and debt, which, if we are able to obtain, will have the effect of diluting our existing common stockholders, perhaps significantly. Any equity or debt financings, if available at all, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be on terms which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> favorable to us and, in the case of equity financings, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>result in dilution to our stockholders. If our operations do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> generate positive cash flow in the upcoming year, or if we are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> able to obtain additional debt or equity financing on terms and conditions acceptable to us, if at all, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be unable to implement our business plan, fund our liquidity needs or even continue our operations.</div></div></div> | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1819000 | |
CY2017Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
55000 | |
CY2016Q4 | us-gaap |
Leasehold Improvements Gross
LeaseholdImprovementsGross
|
48000 | |
CY2017Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1452000 | |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1277000 | |
CY2017Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2079000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-148000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1253000 | |
CY2017 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
36000 | |
CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-47000 | |
CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1552000 | |
CY2017 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-169000 | |
CY2016 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1691000 | |
CY2017Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2865000 | |
CY2016Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2885000 | |
CY2017 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-749000 | |
CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1407000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1041000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
321000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
311000 | |
CY2017Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
305000 | |
CY2017 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
350000 | |
CY2016 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
415000 | |
CY2017Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
86000 | |
CY2016Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
81000 | |
CY2017Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
38000 | |
CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
40000 | |
CY2017 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
928000 | |
CY2016 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
||
CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1799000 | |
CY2017Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
124000 | |
CY2017Q3 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
56000 | |
CY2016 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
||
CY2017 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
11000 | |
CY2016 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
100000 | |
CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
308000 | |
CY2017 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
||
CY2016 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
364000 | |
CY2017 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
139000 | |
CY2016 | us-gaap |
Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
|
202000 | |
CY2017 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
1890000 | |
CY2016 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
||
CY2017 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2162000 | |
CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2499000 | |
CY2017Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-61529000 | |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-61499000 | |
CY2017 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
6862000 | |
CY2016 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
6102000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.1024 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.7546 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0177 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0164 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1662000 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2079000 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.68 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
0.59 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
482000 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
259000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
||
CY2017 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1531000 | |
CY2016 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1637000 | |
CY2017 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18000 | |
CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
96000 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
18000 | |
CY2017 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.26 | |
CY2016 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.28 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2254000 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
2598000 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1746000 | |
CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.64 | |
CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.63 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.68 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
1178000 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1738000 | |
CY2017Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0.68 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.22 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.73 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0.55 | |
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0.35 | |
CY2017 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
||
CY2016 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
1.80 | |
CY2017Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
1662000 | |
CY2017Q4 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
1746000 | |
CY2017Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
0.68 | |
CY2017Q4 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
0.68 | |
CY2017 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
|
P3Y10D | |
CY2017 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
50000 | |
CY2016 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
136000 | |
CY2017Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3509000 | |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3402000 | |
CY2017Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
10000 | |
CY2016Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
10000 | |
CY2017Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
362000 | |
CY2016Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
362000 | |
CY2016Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2017Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2017 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-36pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amount<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">s of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> limited to, the accounting for doubtful accounts, sales discounts, sales returns, revenue recognition, warranty costs, inventory obsolescence, depreciation and income taxes. Actual results could differ from these estimates.</div></div></div></div></div></div></div></div></div></div></div></div> | |
CY2017 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12836000 | |
CY2016 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12737000 | |
CY2017 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12836000 | |
CY2016 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12737000 |